Biosimilars Market is Expected to Grow from USD 27.30 Billion 2023 to reach USD 92 Billion in 2031 | SkyQuest Technology
July 02, 2024 09:30 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, July 02, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the biosimilars market will attain a value of USD 92 billion by 2031, with a CAGR of 16.4% during the forecast period (2024-2031)....